Literature DB >> 7658093

The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients.

D Chargelegue, C M Stanley, C M O'Toole, B T Colvin, M W Steward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7658093     DOI： 10.1093/infdis/172.3.897

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins.

Authors:  T M Ross; Y Xu; T D Green; D C Montefiori; H L Robinson
Journal:  AIDS Res Hum Retroviruses       Date:  2001-06-10       Impact factor: 2.205

2.  Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

Authors:  K S Cole; J L Rowles; B A Jagerski; M Murphey-Corb; T Unangst; J E Clements; J Robinson; M S Wyand; R C Desrosiers; R C Montelaro
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections.

Authors:  K S Cole; M Murphey-Corb; O Narayan; S V Joag; G M Shaw; R C Montelaro
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Authors:  P Mazzetti; S Giannecchini; D Del Mauro; D Matteucci; P Portincasa; A Merico; C Chezzi; M Bendinelli
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Humoral immune response to primary rubella virus infection.

Authors:  Kim M Wilson; Carlie Di Camillo; Larissa Doughty; Elizabeth M Dax
Journal:  Clin Vaccine Immunol       Date:  2006-03

6.  Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

Authors:  Thomas D Green; David C Montefiori; Ted M Ross
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.

Authors:  Jörg Schüpbach; Martin D Gebhardt; Alexandra U Scherrer; Leslie R Bisset; Christoph Niederhauser; Stephan Regenass; Sabine Yerly; Vincent Aubert; Franziska Suter; Stefan Pfister; Gladys Martinetti; Corinne Andreutti; Thomas Klimkait; Marcel Brandenberger; Huldrych F Günthard
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.